[{"id":"4a5c5303-d2d6-439b-bd1d-a7d077defa4f","acronym":"CRESTONE","url":"https://clinicaltrials.gov/study/NCT04383210","created_at":"2021-01-17T17:39:01.678Z","updated_at":"2024-07-02T16:35:40.595Z","phase":"Phase 2","brief_title":"Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors","source_id_and_acronym":"NCT04383210 - CRESTONE","lead_sponsor":"Elevation Oncology","biomarkers":" NRG1","pipe":" | ","alterations":" NRG1 fusion","tags":["NRG1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NRG1 fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e seribantumab (MM-121)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 75","initiation":"Initiation: 09/29/2020","start_date":" 09/29/2020","primary_txt":" Primary completion: 01/01/2025","primary_completion_date":" 01/01/2025","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2023-08-08"}]